Testing multi-sample biomarkers for recurring kidney stones
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks for “biomarkers,” which are measurable signs in samples like urine or blood, to help understand and detect recurring urinary stone disease. It may help future patients by improving how doctors predict stone recurrence or identify stone types.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a history of recurring urinary stones (or you may be in the comparison group with no stone history)
- If you have stone history: you’ve had more than 2 stone episodes (and if stones are on both sides, each side counts as an episode)
- You can give consent to join the study
- You do not have a current urinary infection
- Your stones are not “radiolucent” (not visible on standard X-rays) and not “infective” stones
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a global registry that collects information about people treated for kidney stones. It helps researchers learn about patterns of care and outcomes so treatments can improve over time.
This pilot study looks at how certain gene changes may contribute to calcium oxalate kidney stones. You may be asked for a blood sample and a questionnaire, whether you have a history of stones or not (as a comparison group).
This pilot study tests a new surgical tool that combines a camera and suction to remove kidney stones. It may help people with stones of a certain size get a more efficient procedure.
This study measures a new score called the pelvic floor fatigue index, which looks at how tired the pelvic floor muscles get, in people who have a ureteral stent placed after kidney stone surgery. The goal is to see if this score can help predict or prevent bladder problems that stents can cause.
This study looks at factors that help predict whether a flexible scope procedure to remove kidney or upper ureter stones will be successful. It could help doctors tailor treatment plans and set realistic expectations for patients.
This study looks at whether a specific gut bacteria called Oxalobacter formigenes can help people who form calcium oxalate kidney stones. You will eat a controlled diet and provide samples to see how your body handles oxalate, a substance that can lead to stones.
Hear when a new Urolithiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.